Home > Healthcare > Medical Devices > Therapeutic Devices > Thyroid Ablation Devices Market

Thyroid Ablation Devices Market Share

Report ID: GMI9576
Published Date: May 2024
Report Format: PDF

Download Free Sample

Thyroid Ablation Devices Market Share

The thyroid ablation devices sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Thyroid Ablation Devices Market Companies

Some of the eminent market participants operating in the thyroid ablation devices industry include:

AngioDynamics, Inc.
Boston Scientific Corporation
BVM Medical Limited
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic plc
MedWaves, Inc.
Olympus Corporation
STARmed Co., Ltd.
Stryker Corporation
Terumo Corporation
Theraclion SA

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Thyroid ablation devices industry size was USD 214.1 million in 2023 and is projected to expand at 9.9% CAGR from 2024 to 2032, due to the rising incidences of thyroid cancer and detection of thyroid nodules.

The radiofrequency ablation segment in the thyroid ablation devices industry is projected to reach USD 265.8 million by 2032, owing to the increasing prevalence of thyroid disorders, particularly among the aging population.

The thermal-based devices segment in the thyroid ablation devices industry recorded USD 145.8 million in 2023 and is estimated to witness robust growth between 2024 and 2032, on account of their ability to provide precise, targeted ablation with minimal impact on healthy tissue.

U.S. thyroid ablation devices industry size is projected to be worth USD 180.5 million by 2032, led by the growing aging population with thyroid disorders.